Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Clinical trial NCT05759572 · RECRUITING

Trial details

NCT number: NCT05759572
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2023-02-01
Primary completion: 2025-11-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.